Trifluoromethyl-stabilized optically active oxiranyl and aziridinyl anions for stereospecific syntheses of trifluoromethylated compounds

Tetrahedron

Volumn 59, Issue 49, 2003, Pages 9839-9847

  Yamauchi, Yoshihiro ^a   Kawate, Tomomi ^a   Katagiri, Toshimasa ^a   Uneyama, Kenji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

2,3 epoxy 1,1,1 trifluoropropane; Aziridinyl anion; Fluorinated amino acid; Oxiranyl anion; Quarternary chiral carbon center; Trifluoromethyl group

Indexed keywords

ALDEHYDE DERIVATIVE; ANION; AZIRIDINE DERIVATIVE; EPOXIDE; ETHYLENE OXIDE DERIVATIVE; HALIDE; KETONE DERIVATIVE; METHYL GROUP;

ARTICLE; CHEMICAL REACTION; PRIORITY JOURNAL; REACTION ANALYSIS; STEREOSPECIFICITY; SYNTHESIS;

EID: 0242643064     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2003.09.019     Document Type: Article

References (69)

1. Peters R. Carbon-fluorine compounds chemistry, biochemistry and biological activities. A Ciba Foundation Symposium. 1972;Elsevier, Amsterdam.
2. Soloshonok V.A. EnantioControlled Synthesis of Fluoro-organic Compounds: Stereochemical Challenges and Biomedicinal Targets. 1999;Wiley, Chichester.
3. Kukhar V.P., Soloshonok V.A. Fluorine-containing amino acids: synthesis and properties. 1994;Wiley, Chichester.
4. Welch J.T. Advances in the preparation of biologically active organofluorine compounds. Tetrahedron. 43:1987;3123.
5. Welch J.T., Eswarakrishnan S. Fluorine in Bioorganic Chemistry. 1991;Wiley, New York.
6. For recent example: (a) Magnus N.A., Confalone P.N., Storace L. Tetrahedron Lett. 41:2000;3015 (b) Kauffman G.S., Harris G.D., Dorow R.L., Stone B.R.P., Parsons R.L. Jr., Pesti J.A., Magnus N.A., Fortunak J.M., Confalone P.N., Nugent W.A. Org. Lett. 2:2000;3119 (c) Corbett J.W., Kresge K.J., Pan S., Cordova B.C., Klabe R.M., Rodgers J.D., Erickson-Viitanen S.K. Bioorg. Med. Chem. Lett. 11:2001;309 (d) Tan L., Chen C., Tillyer R.D., Grabowski E.J.J., Reider P.J. Angew. Chem., Int. Ed. 38:1999;711.
7. For recent example: (a) Magnus N.A., Confalone P.N., Storace L. Tetrahedron Lett. 41:2000;3015 (b) Kauffman G.S., Harris G.D., Dorow R.L., Stone B.R.P., Parsons R.L. Jr., Pesti J.A., Magnus N.A., Fortunak J.M., Confalone P.N., Nugent W.A. Org. Lett. 2:2000;3119 (c) Corbett J.W., Kresge K.J., Pan S., Cordova B.C., Klabe R.M., Rodgers J.D., Erickson-Viitanen S.K. Bioorg. Med. Chem. Lett. 11:2001;309 (d) Tan L., Chen C., Tillyer R.D., Grabowski E.J.J., Reider P.J. Angew. Chem., Int. Ed. 38:1999;711.
8. For recent example: (a) Magnus N.A., Confalone P.N., Storace L. Tetrahedron Lett. 41:2000;3015 (b) Kauffman G.S., Harris G.D., Dorow R.L., Stone B.R.P., Parsons R.L. Jr., Pesti J.A., Magnus N.A., Fortunak J.M., Confalone P.N., Nugent W.A. Org. Lett. 2:2000;3119 (c) Corbett J.W., Kresge K.J., Pan S., Cordova B.C., Klabe R.M., Rodgers J.D., Erickson-Viitanen S.K. Bioorg. Med. Chem. Lett. 11:2001;309 (d) Tan L., Chen C., Tillyer R.D., Grabowski E.J.J., Reider P.J. Angew. Chem., Int. Ed. 38:1999;711.
9. For recent example: (a) Magnus N.A., Confalone P.N., Storace L. Tetrahedron Lett. 41:2000;3015 (b) Kauffman G.S., Harris G.D., Dorow R.L., Stone B.R.P., Parsons R.L. Jr., Pesti J.A., Magnus N.A., Fortunak J.M., Confalone P.N., Nugent W.A. Org. Lett. 2:2000;3119 (c) Corbett J.W., Kresge K.J., Pan S., Cordova B.C., Klabe R.M., Rodgers J.D., Erickson-Viitanen S.K. Bioorg. Med. Chem. Lett. 11:2001;309 (d) Tan L., Chen C., Tillyer R.D., Grabowski E.J.J., Reider P.J. Angew. Chem., Int. Ed. 38:1999;711.
10. Dale J.A., Dull D.L., Mosher H.S. J. Org. Chem. 34:1969;2543.
11. (a) Prakash G.K.S., Mandal M. J. Fluorine. Chem. 123:2001;112
12. (b) Aiet-Mohand S., Takechi N., Medebielle M., Dolbier W.R. Jr. Org. Lett. 3:2001;4271
13. (c) Petrov V.A. Tetrahedron Lett. 42:2001;3267
14. (d) Ramachandran P.V., Jennings M.P. Org. Lett. 3:2001;3789
15. (e) Uneyama K., Yan F., Hirama S., Katagiri T. Tetrahedron Lett. 37:1996;2045
16. (f) Bravo P., Capelli S., Meille S.V., Seresini P., Volonterio A., Zanda M. Tetrahedron: Asymmetry. 7:1996;2321
17. (g) Gathergood N., Zhuang W., Jorgensen K.A. J. Am. Chem. Soc. 122:2000;12517
18. (h) Assensio A., Bravo P., Crucianelli M., Farina A., Fustero S., Soler J.G., Meille S.V., Panzeri W., Viani F., Volonterio A., Zanda M. Eur. J. Org. Chem. 2001;1449
19. (i) Volonterio A., Bravo P., Panzeri W., Pesenti C., Zanda M. Eur. J. Org. Chem. 2002;3336
20. (j) Bravo P., Soloshonok V., Farina A., Frigerio M., Meille S.V., Viani F. Tetrahedron: Asymm. 5:1994;987
21. (k) Bravo P., Crucianelli M., Vergani B., Zanda M. Tetrahedron Lett. 39:1998;7771
22. (l) Bravo P., Fustero S., Guidetti M., Volonterio A., Zanda M. J. Org. Chem. 64:1999;8731.
23. For our recent review, see: Katagiri T., Uneyama K. Chirality. 15:2003;4.
24. For review on construction of α-amino acids with α-quaternary carbon, see: (a) Ctiviela C., Diaz-de-Villegas M.D. Tetrahedron: Asymmetry. 9:1998;3517 (b) Ctiviela C., Diaz-de-Villegas M.D. Tetrahedron: Asymmetry. 11:2000;645.
25. For review on construction of α-amino acids with α-quaternary carbon, see: (a) Ctiviela C., Diaz-de-Villegas M.D. Tetrahedron: Asymmetry. 9:1998;3517 (b) Ctiviela C., Diaz-de-Villegas M.D. Tetrahedron: Asymmetry. 11:2000;645.
26. (a) Patel S.T., Percy J.M., Wilkes R.D. Tetrahedron. 51:1995;11327
27. (b) Howarth J.A., Owton W.M., Percy J.M. J. Chem. Soc., Chem. Commun. 1995;757
28. (c) Ichikawa J., Sonoda T., Kobayashi H. Tetrahedron Lett. 30:1989;1641.
29. Yamauchi Y., Katagiri T., Uneyama K. Org. Lett. 4:2002;173
30. Yamauchi Y., Kawate T., Katagiri T., Uneyama K. Tetrahedron Lett. 44:2003;6319.
31. 2-ZnCl, without chirality, had been reported: Fujita M., Hiyama T. Bull. Chem. Soc. Jpn. 60:1987;4377.
32. (a) Jiang B., Xu Y. Tetrahedron Lett. 33:1992;511
33. (b) Jiang B., Xu Y. J. Org. Chem. 56:1991;7336
34. (c) Shi G.-Q., Huang X.-H., Hong F. J. Org. Chem. 61:1996;3200
35. (d) Watanabe H., Yan F.-Y., Sakai T., Uneyama K. J. Org. Chem. 59:1994;758
36. (e) Watanabe H., Yamashita F., Uneyama K. Tetrahedron Lett. 34:1993;1941
37. (f) Uneyama K., Noritake C., Sadamune K. J. Org. Chem. 61:1996;6055
38. (g) Heinze P.L., Burton D.J. J. Org. Chem. 53:1988;2714
39. (h) Morken P.A., Lu H., Nakamura A., Burton D.J. Tetrahedron Lett. 32:1991;4271
40. (i) Knunyants I.L., Stelin R.N., Bogachev V.E. Izv. Akad. Nauk. Ser. Khim. 22:1958;407
41. (j) Spawn T.D., Burton D.J. Bull. Soc. Chim. Fr. 1986;876
42. (k) Miller W., Snider R.H., Hummel R.J. J. Am. Chem. Soc. 91:1969;6532
43. (l) Banks R.E., Haszeldine R.N., Taylor D.R., Webb G. Tetrahedron Lett. 1970;5215
44. (m) Drakesmith F.G., Stwert O.J., Tarrant P. J. Org. Chem. 33:1967;280
45. (n) Fuchikami T., Ojima I. Tetrahedron Lett. 23:1982;4099
46. (o) Fuchikami T., Yamanouchi A., Ojima I. Synthesis. 1984;766
47. (p) Ishikawa N., Yokozawa T. Bull. Chem. Soc. Jpn. 56:1983;724
48. (q) Seebach D., Beck A.K., Renaud P. Angew. Chem., Int. Ed. Engl. 25:1986;98
49. (r) Fuchigami T., Nakagawa Y. J. Org. Chem. 52:1987;5276
50. (s) Fuchigami T., Nakagawa Y., Nonaka T. J. Org. Chem. 52:1987;5489
51. (t) Uneyama K., Momota M. Bull. Chem. Soc. Jpn. 62:1989;3378
52. (u) Qian C.-P., Nakai T. Tetrahedron Lett. 31:1990;7043
53. (v) Beck A.K., Seebach D. Chem. Ber. 124:1991;2897
54. (w) Komatsu Y., Sakamoto T., Kitazume T. J. Org. Chem. 64:1999;8369.
55. For review on this epoxide see: (a) Katagiri T. Soloshonok V.A. Enantiocontrolled Synthesis of Fluoro-Organic Compounds: Stereochemical Challenges and Biomedicinal Targets. 1999;161 Wiley, Chichester, (b) Katagiri T., Uneyama K. J. Fluorine Chem. 105:2000;285 (c) Furuhashi K. Collins A.N., Sheldrake G.N., Crosby J. Chirality in Industry. 1992;Wiley, New York.
56. For review on this epoxide see: (a) Katagiri T. Soloshonok V.A. Enantiocontrolled Synthesis of Fluoro-Organic Compounds: Stereochemical Challenges and Biomedicinal Targets. 1999;161 Wiley, Chichester, (b) Katagiri T., Uneyama K. J. Fluorine Chem. 105:2000;285 (c) Furuhashi K. Collins A.N., Sheldrake G.N., Crosby J. Chirality in Industry. 1992;Wiley, New York.
57. For review on this epoxide see: (a) Katagiri T. Soloshonok V.A. Enantiocontrolled Synthesis of Fluoro-Organic Compounds: Stereochemical Challenges and Biomedicinal Targets. 1999;161 Wiley, Chichester, (b) Katagiri T., Uneyama K. J. Fluorine Chem. 105:2000;285 (c) Furuhashi K. Collins A.N., Sheldrake G.N., Crosby J. Chirality in Industry. 1992;Wiley, New York.
58. Schaus S.E., Brandes B.D., Larrow J.F., Tokunaga M., Hansen K.B., Gould A.E., Furrow M.E., Jacobsen E.N. J. Am. Chem. Soc. 124:2002;1307.
59. (a) Satoh T. Chem. Rev. 96:1996;3303
60. (b) McCoull W., Davis F.A. Synthesis. 2000;1347
61. (c) Capriati V., Degennaro L., Favia R., Florio S., Luisi R. Org. Lett. 4:2002;1551
62. (d) Capriati V., Florio S., Luisi R., Salomone A. Org. Lett. 4:2002;2445.
63. Nahm S., Weinreb S.M. Tetrahedron Lett. 22:1981;3815.
64. Coppola G.A., Schuster H.F. α-Hydroxy Acids in Enantioselecctive Syntheses. 1997;VCH, Weinheim.
65. The strategy for preparation of non-fluorinated amino acids, see: (a) Shao H., Zhu Q., Goodman M. J. Org. Chem. 60:1995;790 (b) Dodd R.H. Molecules. 5:2000;293.
66. The strategy for preparation of non-fluorinated amino acids, see: (a) Shao H., Zhu Q., Goodman M. J. Org. Chem. 60:1995;790 (b) Dodd R.H. Molecules. 5:2000;293.
67. A stronger base, sec-BuLi with TMEDA had been used for generation of aziridinyl and oxiranyl anions: see Ref. 17c and d, also see Luisi R., Capriati V., Florio S., Ranaldo R. Tetrahedron. Lett. 44:2003;2677.
68. (a) Yamamoto K., Miyazawa M. 4th ed. Jikken Kagaku Koza. Vol. 24:1992;Maruzen, Tokyo. p. 14.
69. This method is a modification of the conventional method using sec-BuOH, see: (b) Watson S.C., Eastham J.F. J. Organomet. Chem. 9:1967;165.